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Infectious Diseases in Latin America
and the Caribbean: Are They Really
Emerging and Increasing?
During 1995, infectious disease epidemics in
Latin America and the Caribbean received wide
publicity: dengue throughout the region, Venezue-
lan equine encephalitis (VEE) in Venezuela and
Colombia, and hemorrhagic fever in Nicaragua.
Increased awareness of these diseases followed
extensive reports in the scientific community
about the threat of emerging infections (1,2). Are
infectious diseases increasing in the region or are
we simply seeing the results of better reporting of
persistent problems? Analysis suggests that both
factors are at work.
Dengue and Dengue Hemorrhagic Fever
During the 1950s and 1960s, under the leader-
ship of the Pan American Health Organization
(PAHO), most countries in the Americas success-
fully reduced or eliminated infestation with Aedes
aegypti, the principal vector of dengue and urban
yellow fever. As a result, much of the Americas
became free of dengue. Dengue transmission,
however, persisted in many Caribbean islands and
in some countries of northern South America that
failed to control the vector; therefore, several out-
breaks occurred during the 1960s and in sub-
sequent decades (3).
Ae. aegypti eradication programs, however,
were not sustained and the mosquito reinfested
all Latin American countries except Chile and
Uruguay. As a consequence, dengue spread
throughout the region, causing severe epidemics
or even pandemics during the 1970s and 1980s.
Currently, dengue is endemic in virtually all coun-
tries with Ae. aegypti, and epidemics occur peri-
odically.
Between 1968 and 1980, only 60 suspected or
confirmed cases of dengue hemorrhagic fever
(DHF) were reported, all by five countries in and
around the Caribbean. After the 1981 DHF out-
break in Cuba, reports of DHF in the Americas
markedly increased. The Cuban epidemic was the
most notable event in the history of dengue in the
Americas: almost 400,000 cases of dengue, over
10,000 cases of DHF, and 158 deaths were re-
ported. The Cuban authorities implemented a
successful vector control program and the country
is still virtually free of Ae. aegypti. After this
outbreak, cases of DHF continued to occur in the
Americas, although at relatively low levels, until
1989 when another large epidemic with 2,500
cases of DHF occurred in Venezuela. Since then,
Venezuela has reported large numbers of DHF
cases every year, and in 1995 the country reported
the largest outbreak of dengue/DHF in its history:
almost 30,000 dengue cases and 5,000 DHF cases.
Since 1968, 25 countries of the Americas have
reported more than 35,000 confirmed or suspected
DHF cases and approximately 500 deaths.
In 1995, dengue and DHF activity in the region
was higher than in any year except 1981. As of
November, countries in the Americas had reported
more than 200,000 dengue cases and 6,000 DHF
cases, and approximately 90 deaths. Brazil has
had the largest number of dengue cases, but more
than 80% of the DHF cases occurred in Venezuela.
The reinvasion of the Americas by dengue virus
type 3, which had been absent for 16 years, has
increased the threat of large epidemics and conse-
quent risk for DHF (4). This serotype was isolated
in Panama and Nicaragua at the end of 1994, and
in 1995 it spread to other Central American coun-
tries (except Belize) and Mexico, causing severe
outbreaks. High levels of infestation with Ae.
aegypti are common from the United States to
Argentina, making it likely that dengue epidemics
will increase in frequency and severity.
Cholera
Another disease reemerging in the Americas is
epidemic cholera, which had been absent from this
hemisphere for approximately 90 years before it
was introduced into Peru in January 1991 (5).
Since then more than 1 million cases of cholera
have been reported in 20 countries in the region.
Only Uruguay and the islands of the Caribbean
have been spared. Though the annual total of
reported cases has decreased since 1991, the dis-
ease is persistent and problematic in several Latin
American countries.
Venezuelan Equine Encephalitis
An outbreak of human infection with VEE virus
associated with a large number of equine cases
and deaths was detected in northwestern Vene-
zuela in April 1995. The disease spread to the
adjacent Colombian state of La Guajira in Sep-
tember (6). Unusually heavy rains during 1994
and 1995 contributed to the epidemic by
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Ae. taeniorrhynchus and Psorophora confinnis. Vi-
ral strains with epizootic and epidemic potential
appear to have emerged from enzootic strains
maintained in enzootic rodent-mosquito cycles (7).
In addition, failure to immunize wild and domes-
tic equine populations allowed the virus to amplify
and spread. By mid-October 1995, reported hu-
man cases totaled 26,500 in Venezuela and 22,300
in Colombia, with 24 deaths in the latter. Attack
rates in severely affected communities were 18%
to 57%.
This epidemic of VEE is the largest since that
of 1962-1971, when the disease extended from
northern South America through Central America
and Mexico to the United States (8). Intensified
vector control (including application of adulticides
and larvicides), equine vaccination, and restric-
tion of equine movement appear to have at least
temporarily controlled the epidemic.
Leptospirosis
In late October 1995, Nicaragua reported sev-
eral hundred cases of a hemorrhagic febrile illness
in and near the community of Achuapa, approxi-
mately 110 km northwest of Managua; eight pa-
tients died. The affected communities had
experienced unusually heavy rains and flooding
during the 2 weeks before the cases were noted.
Although dengue was occurring elsewhere in
Nicaragua at the same time, that diagnosis was
excluded by negative laboratory tests and the
absence of Ae. aegypti in the local area. In addi-
tion, some of the patients had frank pulmonary
hemorrhage [not typical of dengue]. By the end of
October, the Centers for Disease Control and Pre-
vention had ruled out dengue, other arboviruses,
and hemorrhagic fever viruses as causes but had
identified leptospira by immunohistochemistry in
tissues from four patients with fatal cases. By
mid-November, the Ministry of Health reported
that 2,480 persons had been ill, 750 were hospital-
ized, and at least 16 died. (Investigation to define
the extent of illness and the responsible serovars
was still in progress at this writing.)
Of the examples discussed here, dengue and
DHF are certainly reemerging. Dengue has been
signaling its return for more than 15 years and
DHF since 1989; these diseases will likely persist
as epidemic problems unless drastic changes in
vector control are achieved. Enzootic VEE has
persisted in northern Venezuela and Colombia
since the previous major epidemic of 1962-1971.
PAHO had urged the countries to increase vacci-
nation coverage of equines because of increased
viral activity in 1993 and 1994. The appearance in
1995 of strains similar to these of the 1962-1971
epidemics, with locally intense transmission,
raised the possibility that VEE would reemerge as
a major epidemic disease. Whether vigorous vec-
tor control measures and immunization programs
have contained that threat is not yet known, but
we must continue to regard the threat as real.
Leptospirosis is a persistent, often under-recog-
nized, problem to which the international commu-
nity has paid relatively little attention. In
Nicaragua, public health interest was sparked by
concern that the epidemic of a new disease would
pose a threat to other communities and countries,
but attention waned as that threat diminished.
Yellow fever, which is usually present in relatively
low numbers in remote areas of South America,
reemerged with force in Peru during 1995. At least
seven departments of that country have been af-
fected (470 cases and a 40% case-fatality rate by
September 1995).
Several factors have contributed to the reemer-
gence of infectious diseases in the Americas. In-
vestments in public health have been decreasing
because of economic recession and a shrinking
public sector or have been diverted from infectious
disease programs to other pressing problems (9).
Human populations throughout the region have
grown and become increasingly urban, with many
living in inadequate housing without sanitation or
potable water. At the same time, population and
commercial pressures have led to the invasion of
forests, exposing people to exotic agents and en-
zootic diseases, including yellow fever, rabies
transmitted by vampire bats, arenaviruses, and
others. Human behavior has contributed to epi-
demic plague in Peru and the rapid spread of
diseases such as cholera. To this list can be added
the effects of deforestation and habitat and cli-
mate change. Unusually heavy rainfall contrib-
uted to at least three of the epidemics considered
in this commentary (10).
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merging) are a real and serious problem in Latin
America and the Caribbean. To combat the threat
of these diseases, PAHO, with the participation of
other institutions in the region, has prepared a
regional plan to improve surveillance for
emerging disease and enhance countries’ ability to
respond effectively by strengthening laboratory
capacity, training, and research and by imple-
menting prevention and control strategies. Minis-
ters of health from countries throughout the
region discussed and endorsed the plan at a meet-
ing of PAHO’s Directing Council in September
1995. Successful implementation of the plan will
require committed action by public health
authorities and collaboration and cooperation by
many institutions and experts throughout the re-
gion.
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Pan American Health Organization
Washington, D.C., USA
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